BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26474031)

  • 1. Correlation Between High-Density Lipoprotein and Monocyte Subsets in Patients with Stable Coronary Heart Disease.
    Jiang S; Li D; Li J; An Y
    Med Sci Monit; 2015 Jun; 21():3129-35. PubMed ID: 26474031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease.
    Krychtiuk KA; Kastl SP; Pfaffenberger S; Pongratz T; Hofbauer SL; Wonnerth A; Katsaros KM; Goliasch G; Gaspar L; Huber K; Maurer G; Dostal E; Oravec S; Wojta J; Speidl WS
    Atherosclerosis; 2014 Dec; 237(2):589-96. PubMed ID: 25463093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis.
    Xiang Y; Liang B; Zhang X; Zheng F
    Int J Med Sci; 2020; 17(14):2171-2179. PubMed ID: 32922178
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating CD14+CD16+ monocyte subsets as biomarkers of the severity of coronary artery disease in patients with stable angina pectoris.
    Ozaki Y; Imanishi T; Taruya A; Aoki H; Masuno T; Shiono Y; Komukai K; Tanimoto T; Kitabata H; Akasaka T
    Circ J; 2012; 76(10):2412-8. PubMed ID: 22785372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a).
    Krychtiuk KA; Kastl SP; Hofbauer SL; Wonnerth A; Goliasch G; Ozsvar-Kozma M; Katsaros KM; Maurer G; Huber K; Dostal E; Binder CJ; Pfaffenberger S; Oravec S; Wojta J; Speidl WS
    J Clin Lipidol; 2015; 9(4):533-41. PubMed ID: 26228671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of CD14
    Yamamoto H; Yoshida N; Shinke T; Otake H; Kuroda M; Sakaguchi K; Hirota Y; Toba T; Takahashi H; Terashita D; Uzu K; Tahara N; Shinkura Y; Kuroda K; Nagasawa Y; Nagano Y; Tsukiyama Y; Yanaka KI; Emoto T; Sasaki N; Yamashita T; Ogawa W; Hirata KI
    Atherosclerosis; 2018 Feb; 269():245-251. PubMed ID: 29407600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease.
    Czepluch FS; Kuschicke H; Dellas C; Riggert J; Hasenfuss G; Schäfer K
    J Intern Med; 2014 Feb; 275(2):144-54. PubMed ID: 24118494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between high density lipoprotein and monocyte subpopulations among stable coronary atherosclerotic heart disease patients.
    Yang RH; Liu YF; Wang XJ; Liang JG; Liu JC
    Int J Clin Exp Med; 2015; 8(9):16969-77. PubMed ID: 26629252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating intermediate CD14++CD16+monocytes are increased in patients with atrial fibrillation and reflect the functional remodelling of the left atrium.
    Suzuki A; Fukuzawa K; Yamashita T; Yoshida A; Sasaki N; Emoto T; Takei A; Fujiwara R; Nakanishi T; Yamashita S; Matsumoto A; Konishi H; Ichibori H; Hirata KI
    Europace; 2017 Jan; 19(1):40-47. PubMed ID: 26826137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease.
    Rogacev KS; Zawada AM; Emrich I; Seiler S; Böhm M; Fliser D; Woollard KJ; Heine GH
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2120-7. PubMed ID: 25060791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD14
    Urbanski K; Ludew D; Filip G; Filip M; Sagan A; Szczepaniak P; Grudzien G; Sadowski J; Jasiewicz-Honkisz B; Sliwa T; Kapelak B; McGinnigle E; Mikolajczyk T; Guzik TJ
    Thromb Haemost; 2017 May; 117(5):971-980. PubMed ID: 28229168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Toll-Like Receptor 4 on Human Monocyte Subsets and Vulnerability Characteristics of Coronary Plaque as Assessed by 64-Slice Multidetector Computed Tomography.
    Ozaki Y; Imanishi T; Hosokawa S; Nishiguchi T; Taruya A; Tanimoto T; Kuroi A; Yamano T; Matsuo Y; Ino Y; Kitabata H; Kubo T; Tanaka A; Akasaka T
    Circ J; 2017 May; 81(6):837-845. PubMed ID: 28344199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry.
    Thomas GD; Hamers AAJ; Nakao C; Marcovecchio P; Taylor AM; McSkimming C; Nguyen AT; McNamara CA; Hedrick CC
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1548-1558. PubMed ID: 28596372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shift of monocyte subsets along their continuum predicts cardiovascular outcomes.
    Cappellari R; D'Anna M; Bonora BM; Rigato M; Cignarella A; Avogaro A; Fadini GP
    Atherosclerosis; 2017 Nov; 266():95-102. PubMed ID: 29017104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate CD14
    Lo SC; Lee WJ; Chen CY; Lee BC
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1223-1236. PubMed ID: 28239800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "Intermediate" CD14
    Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A
    Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies against macrophage colony-stimulating factor diminish the number of circulating intermediate and nonclassical (CD14(++)CD16(+)/CD14(+)CD16(++)) monocytes in rheumatoid arthritis patient.
    Korkosz M; Bukowska-Strakova K; Sadis S; Grodzicki T; Siedlar M
    Blood; 2012 May; 119(22):5329-30. PubMed ID: 22653956
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipoprotein apheresis influences monocyte subpopulations.
    Jellinghaus S; Reich C; Schatz U; Tselmin S; Ibrahim K; Pfluecke C; Schauer A; Bornstein SR; Hohenstein B; Strasser RH; Julius U; Poitz DM
    Atheroscler Suppl; 2017 Nov; 30():108-114. PubMed ID: 29096825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Admission Low-Density Lipoprotein Cholesterol Stratified by Circulating CD14++CD16+ Monocytes and Risk for Recurrent Cardiovascular Events Following ST Elevation Myocardial Infarction: Lipid Paradox Revised.
    Dong S; Ji W; Zeng S; Miao J; Yan L; Liu X; Liu J; Zhou X; Yang Q
    J Cardiovasc Transl Res; 2020 Dec; 13(6):916-927. PubMed ID: 32557321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease.
    Krychtiuk KA; Kastl SP; Pfaffenberger S; Lenz M; Hofbauer SL; Wonnerth A; Koller L; Katsaros KM; Pongratz T; Goliasch G; Niessner A; Gaspar L; Huber K; Maurer G; Dostal E; Wojta J; Oravec S; Speidl WS
    PLoS One; 2015; 10(4):e0123367. PubMed ID: 25849089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.